source
- Altimmune rises as GLP-1/glucagon drug curbs heavy drinking in mid-stage studyPemvidutide showed a “highly statistically significant” treatment effect in patients with alcohol use disorder. Altimmune is going up against Eli Lilly and newcomer Baseline Therapeutics, among oth…
- Anthony Fauci’s pandemic-era diary entriesNew data on American substance use, concerns of a global HIV resurgence, and more health news from Morning Rounds